Donna’s Story

Making personalized possibilities a reality
with the Vysis ALK Break Apart FISH Probe Kit
Watch Full Story (4:05 min)

Meet DonNa

In 2007, a biopsy revealed Donna Gaidamak had Stage 4 lung cancer that had metastasized to her brain. Donna was tested for the ALK gene rearrangement with the Vysis ALK Break Apart FISH Probe Test Kit from Abbott. Results proved she was ALK positive and she was immediately put on XALKORI® (crizotinib). Today, Donna is back to doing the activities she loves: biking, skiing, kayaking and sailing.

 
 
           

  

ALK Break Apart FISH Probe KitRelated Product

Intended Use

The Vysis ALK Break Apart FISH Probe Kit is intended to detect rearrangements involving the ALK gene via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens.

View Product Details 

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No